CD45RO+ CD27+ CD4+ T cells

1. Pomalidomide decreases CD45RO+ CD27+ CD4+ T cells in humans.

   “a decrease in CD45RO - CD27 - (effector) CD4 + cells ( P = 0.0002)”

   Human trialin patients with Kaposi sarcoma5 mg3 cyclesn = 19

   Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration

   AIDS (London, England)·Jun 19, 2023

2. Pomalidomide increases CD45RO+ CD27+ CD4+ T cells in humans.

   “After three cycles, pomalidomide led to an increased proportion of CD45RO + CD27 + (central memory) CD4 + ( P = 0.002) and CD8 + ( P = 0.002) T cells”

   Human trialin patients with Kaposi sarcoma5 mg3 cyclesn = 19

   Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration

   AIDS (London, England)·Jun 19, 2023

More on Pomalidomide